Reduced Intensity Conditioning (RIC) Regimen and Post-transplant Cyclophosphamide in Haploidentical Bone Marrow Transplantation in in Patients With Poor Prognosis Lymphomas

NCT02049580 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Thiotepa
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Istituto Clinico Humanitas